NCT07493252

A Behavioral Application for Improving Smoking Cessation Among Smokers

Actify! An mHealth Mood Management Tool to Improve Population-Level Smoking Cessation

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,812 (estimated)
• Sponsor: Fred Hutchinson Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This clinical trial compares two smartphone applications, called Actify! (A \& B) for improving smoking cessation outcomes in individuals who smoke. Actify! A is an app grounded in behavioral activation therapy, an evidence-based treatment for depression that can also be used to modify health behaviors such as smoking. The Actify! B app provides evidence-based tobacco cessation strategies based on current clinical guidelines.

Detailed description

OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants use the Actify! A app, which helps users identify personal values and meaningful activities, prompts users to schedule and complete meaningful activities, visualizes progress towards meeting activity and smoking-related goals, and provides tailored messages, resources, daily tips, personalized feedback, inspirational messages, and user stories, for 8 weeks on study. ARM II: Participants use the Actify! B app, which contains quit advice, tools for tracking smokefree days, progress and cravings, guidance on preparing to quit, managing cravings and withdrawal, recovering from slips, and a mood management feature, for 8 weeks on study. After completion of study intervention, participants are followed up at 6 months.

Conditions

• Cigarette Smoking-Related Carcinoma

Interventions

Type	Name	Description
BEHAVIORAL	Smartphone app-based Intervention (Actify! A app)	Use Actify! A app
BEHAVIORAL	Smartphone app-based Intervention (Actify! B app)	Use Actify! B app
OTHER	Health Promotion and Education	Receive motivational messages and smoking cessation information via text messages
OTHER	Survey Administration	Ancillary studies

Timeline

• Start date: 2026-08-01
• Primary completion: 2029-07-31
• Completion: 2029-07-31
• First posted: 2026-03-25
• Last updated: 2026-03-25

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study